CSIMarket
 


Enzon Pharmaceuticals inc   (ENZN)
Other Ticker:  
 
 

Enzon Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Enzon Pharmaceuticals Inc asset turnover ratio, the ability of Enzon Pharmaceuticals Inc 's assets to generate revenue in the forth quarter 2023, increased sequentially to 0.05 in the fourth quarter (Dec 31 2023), yet the ratio remained below the average, as ENZN's position remain challenging.

Within sector 34 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2023, to 2395, from total ranking in the third quarter 2023 at 3701.


What is Asset Turnover Ratio?
What is Enzon Pharmaceuticals Inc Market Share?


ENZN Asset Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Asset Change 0.24 % -0.55 % -1.17 % -2.05 % -0.35 %
Y / Y Revenue Change 2357.69 % - - - -10.34 %
Asset Turnover Ratio (TTM) 0.05 0.04 0.02 0.01 0
ENZN's Total Ranking # 2395 # 3701 # # #
Seq. Asset Change 1.5 % 0.7 % 0.38 % -2.3 % 0.7 %
Seq. Revenue Change 2.73 % 12.48 % 23.71 % 1619.23 % -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 35
Healthcare Sector # 321
Overall Market # 2395

Asset Turnover Ratio Statistics
High Average Low
2.15 0.56 -0.02
(March 31, 2014)   (Sep 30 2018)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Zymeworks Inc   0.13 $ 76.012  Millions$ 585.011  Millions
Prothena Corporation Public Limited Company  0.13 $ 91.370  Millions$ 726.384  Millions
Lipella Pharmaceuticals Inc   0.12 $ 0.450  Millions$ 3.631  Millions
Intelgenx Technologies Corp   0.12 $ 1.070  Millions$ 8.982  Millions
Hookipa Pharma inc   0.12 $ 20.129  Millions$ 169.886  Millions
Morphosys Ag  0.12 $ 266.872  Millions$ 2,269.469  Millions
Curis Inc   0.12 $ 10.023  Millions$ 86.527  Millions
Werewolf Therapeutics Inc   0.11 $ 19.943  Millions$ 182.881  Millions
Pacific Biosciences Of California Inc   0.11 $ 199.780  Millions$ 1,847.104  Millions
Foghorn Therapeutics Inc   0.10 $ 34.155  Millions$ 327.950  Millions
Arcus Biosciences Inc   0.10 $ 117.000  Millions$ 1,190.000  Millions
Biocardia Inc  0.09 $ 0.477  Millions$ 5.063  Millions
Caribou Biosciences Inc   0.09 $ 34.477  Millions$ 396.710  Millions
Omniab Inc   0.09 $ 34.164  Millions$ 396.303  Millions
Ac Immune Sa  0.08 $ 14.801  Millions$ 182.814  Millions
Igc Pharma Inc   0.08 $ 1.215  Millions$ 15.154  Millions
Dbv Technologies S a   0.08 $ 15.728  Millions$ 205.804  Millions
Soligenix inc   0.07 $ 0.839  Millions$ 11.507  Millions
Recursion Pharmaceuticals Inc   0.07 $ 44.575  Millions$ 644.647  Millions
Arch Therapeutics Inc   0.07 $ 0.115  Millions$ 1.734  Millions
Vaxart Inc   0.07 $ 7.379  Millions$ 112.494  Millions
Co diagnostics Inc   0.06 $ 6.627  Millions$ 108.450  Millions
Delcath Systems Inc   0.06 $ 2.065  Millions$ 34.460  Millions
C4 Therapeutics Inc   0.06 $ 20.756  Millions$ 370.127  Millions
Bicycle Therapeutics Plc  0.05 $ 26.976  Millions$ 529.250  Millions
Enzon Pharmaceuticals inc   0.05 $ 2.261  Millions$ 46.967  Millions
Meiragtx Holdings Plc  0.05 $ 14.017  Millions$ 298.085  Millions
Armata Pharmaceuticals Inc   0.04 $ 4.529  Millions$ 105.279  Millions
Inovio Pharmaceuticals Inc   0.04 $ 8.965  Millions$ 215.917  Millions
Lumos Pharma Inc   0.04 $ 2.051  Millions$ 52.122  Millions

Date modified: 2024-03-25T16:50:09+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com